Activation of p53 was shown to induce apoptosis in bulk and CD34+CD38− BC CML cells, as well as in proliferating and, most importantly, in TKI-insensitive, CD34+ quiescent BC CML progenitor cells. This evidence concerns the gene TP53 and breast cancer.